The WHO defines an endocrine disruptor as ‘an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations’. This definition has been retained by the European Union, which started a number of developments to better regulate these substances in […]
developments
Cannabis derivatives such as Hemp seed oil and Cannabidiol (CBD) are very fashionable those last days and many cosmetic brands pay attention to this new market trend. As usual, new developments, new technologies and new practices raise legal questions and the European Authorities start to raise questions (and sometimes concerns) about these Cannabis derivatives. Following […]
Important regulatory development focusing on fragrance allergens The European Commission and the trade associations (IFRA, Cosmetics Europe, UEAPME, etc.) worked for years on this future piece of legislation and its adoption is expected to take place in February 2016 although there is no certainty about the exact date. Background The European Cosmetics Regulation provides that […]
Several important cosmetic ingredients are currently in the process of being regulated by the EU Commission and the biggest uncertainty now concerns the timeline for enforcement and implementation of these new risk management measures. Biorius informed you about several ongoing issues and made assumptions on when these amendments of the EU Cosmetics Regulation would get […]
